Literature DB >> 3931088

Prostaglandin modulation of the vascular effects of vasopressin in the conscious rat.

B R Walker.   

Abstract

Experiments were performed on conscious, male Sprague-Dawley rats to determine whether cyclooxygenase inhibition affects the pressor response to exogenous vasopressin. The rise in arterial blood pressure was tested in response to 1.0, 2.5, 5.0, and 12.5 mU synthetic arginine vasopressin both before and following cyclooxygenase inhibition with either meclofenamate or the structurally dissimilar inhibitor ibuprofen. In addition, time control experiments were also performed where only the saline vehicle for the drugs was administered. In all animals tested, the increase in arterial pressure in response to the highest three concentrations of vasopressin was greater following cyclooxygenase inhibition than before, while the saline vehicle had no effect. The baroreceptor-mediated bradycardia accompanying the rise in blood pressure was variable, but unaffected by meclofenamate or ibuprofen. It is concluded that vasodilator prostaglandins are released in response to pressor levels of vasopressin, which act to modulate the pressor response of the peptide.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3931088     DOI: 10.3181/00379727-180-42173

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  3 in total

1.  Effects of NG-nitro-L-arginine methyl ester or indomethacin on differential regional and cardiac haemodynamic actions of arginine vasopressin and lysine vasopressin in conscious rats.

Authors:  S M Gardiner; A M Compton; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

2.  The influence of vasopressin on the arterioles and venules of skeletal muscle of the rat during systemic hypoxia.

Authors:  J M Marshall; J Lloyd; R Mian
Journal:  J Physiol       Date:  1993-10       Impact factor: 5.182

3.  Age dependency of vasopressin pulmonary vasodilatory effect in rats.

Authors:  Masahiro Enomoto; Jingyi Pan; Yulia Shifrin; Jaques Belik
Journal:  Pediatr Res       Date:  2013-11-20       Impact factor: 3.756

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.